Outlook Therapeutics, Inc.
NASDAQ:OTLKBiotechnology
Healthcare
$0.40 -5.76%
-$0.10 today
- Market cap
- $97.62M
- Beta
- 0.98
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$0.74
52W Low $0.16High $3.39
Volume 6.81M
Average 17.46M
Price history
Outlook Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-78.67%
Period high
$2.47
Period low
$0.20
Latest
$0.40
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Oct 13, 2026 | Oct 13, 2026 | |
| 8-K | Sep 30, 2026 | Sep 30, 2026 | |
| 8-K | Sep 18, 2026 | Sep 18, 2026 | |
| 4 | Sep 2, 2026 | Sep 2, 2026 | |
| 3 | Sep 2, 2026 | Sep 2, 2026 | |
| 8-K | Aug 27, 2026 | Aug 27, 2026 | |
| SC 13G | Aug 19, 2026 | Aug 19, 2026 | |
| 10-Q | Aug 18, 2026 | Aug 18, 2026 | |
| NT 10-Q | Aug 17, 2026 | Aug 17, 2026 | |
| 8-K | Aug 14, 2026 | Aug 14, 2026 | |
| 4 | Aug 14, 2026 | Aug 14, 2026 | |
| 4 | Aug 14, 2026 | Aug 14, 2026 | |
| 4 | Aug 14, 2026 | Aug 14, 2026 | |
| 424B5 | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13D/A | Aug 14, 2026 | Aug 14, 2026 |
Competitors
Who does Outlook Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about OTLK's filings, answered from its disclosures.
What is the latest OTLK filing?
The latest filing shown is SC 13G dated Oct 13, 2026.
How many recent filings does OTLK have?
Intrinsic Alpha currently shows 20 recent filings for OTLK.
Continue the stock analysis
Jump to another research area for this company.